Jamie Page has extensive experience in healthcare in both the public and private sectors. He graduated in 1979 with a B.Sc in Chemistry from Imperial College, London, before working in the Royal Marsden Hospital and later the Royal Postgraduate Medical School at the Hammersmith Hospital, part of a group investigating the cellular immune response to cytomegalovirus, a herpes virus.
After gaining an MBA in 1984 from INSEAD, Europe’s leading business school, Jamie Page worked for a number of well-known companies including ICI, Biogen, Serono and Hoffmann-La Roche. Much of his career has involved development and commercialisation of therapeutic proteins, most notably the cancer and hepatitis therapeutic, alfa interferon.
In the late 1990s he left the private sector to become more involved in preventative medicine, believing it is vital to reduce human exposure to harmful chemicals. In 2001 he founded the Cancer Prevention and Education Society (CPES), a UK-based charity working to reduce the incidence of cancer and other diseases by raising awareness of the connection between diseases and exposure to chemical substances.
Board of Trustees
CPES was established to reduce the incidence of cancer and other diseases. There is an ever-increasing scientific literature reporting links between exposures to man-made chemicals and pollution to cancer and other diseases: developmental and reproductive disorders, infertility, IQ reduction, thyroid disease, etc. However, a lot of this literature is confined to specialist journals, and therefore difficult to access.
The Society was created to convey this specialised research to key audiences including doctors, scientists, regulators, policy makers and politicians. Although our work benefits everyone it is targeted to “technical” audiences who have the power to reduce human exposure to hazardous chemicals and pollution. And while we are by no means anti-chemical, we do believe that risks to health posed by chemical substances are inadequately evaluated prior to commercialisation. Therefore, in addition to improved regulatory control of chemicals prior to market access, we support the emerging discipline of green chemistry where the health and environmental effects of novel chemicals are considered, or, in other words, they are ‘benign by design’.
We depend entirely on individual donations and therefore need the support of all people who want to prevent cancer and other diseases. We act on your behalf to make the case to the people who can do something about it.
Jamie joined Burmah Castrol in 1991 and rose to Chief Executive of Burmah Castrol Chemicals before leading the buy-out of Foseco in 2001 and its subsequent flotation in 2005. He was Chief Executive of Foseco plc until it was acquired by Cookson Group plc in April 2008.
Currently non-executive Chairman of Ibstock plc and Senior Independent Director of Spirax-Sarco Engineering plc. Previously non-executive Chairman of Tyman plc and a non-executive director of RMC Group plc, Kelda Group plc and the Defence Support Group. He was also Chairman of a US plastics recycling business, MBA Polymers Inc and Lafarge Tarmac Holdings Limited.
David Griffiths is a director of Dotmatix Technologies Limited. He was a partner in Clifford Chance LLP from 1990 to 2010 where he specialised in corporate and technology transactions and was leader of Clifford Chance’s international outsourcing group. He was educated at Cambridge and qualified as a solicitor in 1983. He is also chairman of The National Byway Trust.
Jane is a former Independent Television News journalist, Parliamentary Lobby Correspondent, TV documentary maker and radio broadcaster. After 25 years working in television she joined Positive News as co-Director and Editor. Jane is a Fellow of the Royal Society for the Encouragement of Arts, Manufactures and Commerce and a member of The Club of Budapest.
Antonia first became interested in environmental causes of disease while raising her three young children in London, and it came as a shock to her to learn that chemicals in consumer products were not properly evaluated by regulatory authorities for their safety prior to being put on the market. Her role as a Trustee of CPES is as a layperson and concerned mother. She is also the Secretary of the Charity.
The Cancer Prevention and Education Society is a Charity (No. 1089082) & Company Limited by
Guarantee (No. 4157505). Registered in England and Wales. Registered Office:
The Cancer Prevention & Education Society, Meads House, Leighterton, Tetbury, Gloucestershire, GL8 8UW.